Rheumatoid arthritis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of outpatient. 2. 20 years of age or older, the age of consent at the time of acquisition of male and female patients. 3. During treatment, or there is a history of treatment using DMARDs, but patients who have not been confirmed sufficiently therapeutic effect of the current situation 4. Patients who signed the consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with the possibility of pregnancy or during pregnancy. 2. Currently, persons participating in the clinical trials of the same species and effect.(Phase1-3) 3. Person as an object of study, the attending physician is determined to be undesirable.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency and the progression of joint involvement. | — |
Secondary
| Measure | Time frame |
|---|---|
| a. Correlation between therapeutic effect and the progression of joint involvement b. Stratified analysis in the patient background. | — |
Countries
Japan
Contacts
Nagasaki University Hospital Department of Immunology and Rheumatology Nagasaki University Graduate School of Biomedical Sciences